Skip to main content
. Author manuscript; available in PMC: 2009 Sep 17.
Published in final edited form as: Neuropsychopharmacology. 2008 Feb 27;33(12):2791–2800. doi: 10.1038/npp.2008.17

Figure 5.

Figure 5

Changes in anxiety (VAS) after 150 mg caffeine in European-American participants for genotypic groups at DRD2 rs1110976 Intron 6. Bars represent mean ± SEM peak change from pre-capsule baseline. The asterisk denotes a significant difference between the genotypes (P<0.006).